Comparative effects of exercise and warm footbath on pain and fatigue in patients with chemotherapy-induced peripheral neuropathy

Comparative effects of exercise and warm footbath on pain and fatigue in patients with chemotherapy-induced peripheral neuropathy: a quasi-experimental study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0011563

Enrollment

Registered

2026-02-02

Start date

2026-02-09

Completion date

Unknown

Last updated

2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral, Others : This study compares the effects of exercise therapy and footbath therapy in inpatients with Chemotherapy-Induced Peripheral Neuropathy (CIPN). Participants are allocated based on

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Adults aged 19 years or older diagnosed with cancer who have undergone chemotherapy at least once. 2. Patients currently experiencing sensory symptoms (pain, numbness, etc.) related to chemotherapy-induced peripheral neuropathy (CIPN) and reporting symptoms in the sensory domain of the EORTC QLQ-CIPN20. 3. Inpatients at the study site or those scheduled for continuous hospitalization during the study period. 4. Patients capable of communication who have voluntarily provided written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with central or peripheral nervous system diseases unrelated to chemotherapy (e.g., stroke, Parkinson's disease, spinal cord injury). 2. Patients with unstable systemic conditions (e.g., acute infection, fever) for whom the intervention is deemed unsafe. 3. Patients with moderate to severe cognitive impairment or difficulty in communication/consent. 4. Patients on complete bed rest or with limited voluntary movement preventing exercise participation. 5. Patients with open wounds, skin lesions, or diabetic foot issues on lower extremities preventing footbath. 6. Patients receiving other intensive non-pharmacological interventions for CIPN concurrently during the study period.

Design outcomes

Primary

Measure	Time frame
Chemotherapy-Induced Peripheral Neuropathy Symptom Score (Assessed by EORTC QLQ-CIPN20)	—

Secondary

Measure	Time frame
Fatigue Level Score (Assessed by EORTC QLQ-FA12)	—

Countries

Korea, Republic of

Contacts

Public ContactSangRyun Jo

Jeonbuk National University

sangryunjo98@gmail.com+82-63-323-7517

Outcome results